36307-23-0

Basic information

• Product Name: 5-(3-hydroxypropyl)-7-methoxy-3-methyl-2-(3'-methoxy-4'-hydroxyphenyl)benzofuran

Upstream product

• 135040-83-4 5-(3-hydroxypropyl)-7-methoxy-2-(3'-methoxy-4'-hydroxyphenyl)-3-benzo[b]furan-carbaldehyde 
• 7647-01-0 hydrogenchloride 
• 67-56-1 methanol 
• 125874-72-8 3-[2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propan-1-ol 
• 67-66-3 chloroform 
• 10035-10-6 hydrogen bromide 
• 220570-30-9 2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-methyl-5-[l(E)-3-oxopropenyl]benzofuran 
• 921767-78-4 trans-2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-methyl-5-(E)-propenylbenzofuran 
• 5932-68-3 (E)-2-methoxy-4-(1-propenyl)phenol 
• 121-33-5 vanillin 
• 1835-11-6 4-benzyloxy-3-methoxyacetophenone 
• 2973-76-4 5-bromo-4-hydroxy-3-methoxybenzaldehyde 
• 61222-88-6 methyl 3-methoxy-4-hydroxy-5-bromocinnamate 
• 135040-88-9 2-(4-hydroxy-3-methoxyphenyl)-5-(3-acetoxypropyl)-7-methoxybenzofuran 

Downstream Products

• 135040-83-4 5-(3-hydroxypropyl)-7-methoxy-2-(3'-methoxy-4'-hydroxyphenyl)-3-benzo[b]furan-carbaldehyde 

Relevant articles and documents

CAFFEIC ACID DERIVATIVES FOR ANTI-ANGIOGENESIS

The present invention develops a series of methyl caffeate derivatives having biological activity in anti-angiogenesis. The present invention suggests that the compounds of the invention possess inhibiting angiogenesis through regulation of VEGF/VEGFR-2 a

Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzofurans: Synthesis of a Novel Adenosine A1 Receptor Ligand and Its Derivatives

By maintaining the balance between the electronic requirements, the stereochemical restrictions as well as the kinetic and thermodynamic factors, the unprecedented regioselective electrophilic aromatic substitution of formyl and nitro groups to carbon-3 o